Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer

Prof Ken Kato - National Cancer Center Hospital, Chuo-ku, Japan
KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer ( Prof Ken Kato - National Cancer Center Hospital, Chuo-ku, Japan )
24 Sep 2020

Disparities in access to oncology clinical trials across Europe

Prof Ana Carneiro - Lund University, Lund, Sweden
Disparities in access to oncology clinical trials across Europe ( Prof Ana Carneiro - Lund University, Lund, Sweden )
24 Sep 2020

ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC

Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC ( Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA )
23 Sep 2020

ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer patients

Prof Sanjay Popat - The Royal Marsden Hospital, London, UK
ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer patients ( Prof Sanjay Popat - The Royal Marsden Hospital, London, UK )
23 Sep 2020

Breast cancer roundup from ESMO 2020

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Breast cancer roundup from ESMO 2020 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
23 Sep 2020

OncoAlert and ecancer weekly roundup for September 14-19, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 14-19, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
23 Sep 2020

IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer

Prof Leisha Emens - University of Pittsburgh, Pittsburgh, USA
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer ( Prof Leisha Emens - University of Pittsburgh, Pittsburgh, USA )
22 Sep 2020

ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer

Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan
ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer ( Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan )
22 Sep 2020

Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or PD-L1 inhibitor: initial results of LEAP-004

Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or PD-L1 inhibitor: initial results of LEAP-004 ( Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain )
22 Sep 2020

Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC after tumour resection

Dr Masahito Tsuboi - National Cancer Center Hospital, Tokyo, Japan
Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC after tumour resection ( Dr Masahito Tsuboi - National Cancer Center Hospital, Tokyo, Japan )
22 Sep 2020

Latest updates to the ESMO bone health guidelines

Prof Robert Coleman - University of Sheffield, Sheffield, UK
Latest updates to the ESMO bone health guidelines ( Prof Robert Coleman - University of Sheffield, Sheffield, UK )
22 Sep 2020

CheckMate 649: Nivolumab plus chemotherapy for gastric and oesophageal cancers

Prof Markus Möhler - Universitätsmedizin Mainz, Mainz, Germany
CheckMate 649: Nivolumab plus chemotherapy for gastric and oesophageal cancers ( Prof Markus Möhler - Universitätsmedizin Mainz, Mainz, Germany )
22 Sep 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation